Improved stability and selectivity of lytic peptides through self-assembly

Area of Science:

• Biomaterials Science
• Drug Delivery Systems
• Peptide Therapeutics

Background:

• Peptide drugs face limitations in clinical use due to poor stability and selectivity, leading to short lifespans and normal tissue damage.
• High dosages are often required to overcome these limitations, exceeding clinical and economic acceptability.

Purpose of the Study:

• To design novel lytic peptides capable of self-assembly into stable nanostructures.
• To investigate the properties of these self-assembled peptide fibrils, including enzyme resistance and controlled release.

Main Methods:

• Design of novel lytic peptides.
• Characterization of self-assembled peptide fibrils using atomic force microscopy.
• Evaluation of enzyme degradation resistance.
• Assessment of reversible self-assembly and controlled peptide release.

Main Results:

• Lytic peptides self-assembled into peptide fibrils with defined nanostructures.
• Self-assembled fibrils demonstrated resistance to enzymatic degradation.
• The self-assembly process was reversible and environment-dependent.
• Controlled, concentration-dependent sustained release of active lytic peptide was achieved.

Conclusions:

• Self-assembled lytic peptides exhibit enzyme resistance, sustained release, and prodrug characteristics.
• This approach holds significant potential for advancing peptide drug clinical applications.